These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19883893)

  • 1. Insulin glargine induced persistent intractable hypoglycemia, with variable presentations in older diabetic patients: an experience of 4 cases.
    Kumari J; Dharmarajan TS
    J Am Med Dir Assoc; 2009 Nov; 10(9):672-3. PubMed ID: 19883893
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of diabetic cats with long-acting insulin.
    Roomp K; Rand JS
    Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):251-66. PubMed ID: 23522171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies.
    Xie L; Wei W; Pan C; Baser O
    J Med Econ; 2013 Sep; 16(9):1137-45. PubMed ID: 23859434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice.
    Ross S; Dzida G; Ji Q; Kaiser M; Ligthelm R; Meneghini L; Nazeri A; Orozco-Beltran D; Pan C; Svendsen AL;
    J Diabetes; 2014 May; 6(3):243-50. PubMed ID: 24103141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes.
    Levin P; Wei W; Wang L; Pan C; Douglas D; Baser O
    Curr Med Res Opin; 2012 Mar; 28(3):439-46. PubMed ID: 22216894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.
    Cansu DU; Korkmaz C
    Rheumatology (Oxford); 2008 Mar; 47(3):378-9. PubMed ID: 18222983
    [No Abstract]   [Full Text] [Related]  

  • 10. Lantus insulin overdose: a case report.
    Lu M; Inboriboon PC
    J Emerg Med; 2011 Oct; 41(4):374-7. PubMed ID: 20493654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy.
    Pawaskar MD; Blickensderfer AL; Hoogwerf BJ; Quimbo R; Wade R
    J Med Econ; 2011; 14(6):705-8. PubMed ID: 21892855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycaemia after treatment with perhexiline maleate: a case report.
    Lai B
    N Z Med J; 2011 Mar; 124(1330):74-7. PubMed ID: 21681255
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucose or intermittent high-intensity exercise in glargine/glulisine users with T1DM.
    Dubé MC; Lavoie C; Weisnagel SJ
    Med Sci Sports Exerc; 2013 Jan; 45(1):3-7. PubMed ID: 22895370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of different statistical methods analyzing hypoglycemia data using bootstrap simulations.
    Jiang H; Ni X; Huster W; Heilmann C
    J Biopharm Stat; 2015; 25(1):54-65. PubMed ID: 24905704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus.
    Polonsky W; Traylor L; Wei W; Shi R; Ameer B; Vlajnic A; Nicolucci A
    Diabetes Obes Metab; 2014 Mar; 16(3):255-61. PubMed ID: 24028669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of 46 cats with porcine lente insulin--a prospective, multicentre study.
    Michiels L; Reusch CE; Boari A; Petrie G; Mandigers P; Thollot IG; Rosenberg D; Mooney C; Bonfanti U; Font A; Sparkes A; Bewig K; Clercx C; Jensen AL; Horspool LJ
    J Feline Med Surg; 2008 Oct; 10(5):439-51. PubMed ID: 18619886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of insulin glargine in children and adolescents with type 1 diabetes.
    Tan CY; Wilson DM; Buckingham B
    Pediatr Diabetes; 2004 Jun; 5(2):80-6. PubMed ID: 15189493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical moment with ... diabetes. Why did my symptoms of hypoglycemia change?
    DeLawter DE
    Md Med J; 1991 Jul; 40(7):594. PubMed ID: 1861589
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin degludec--the impact of a new basal insulin on care in type 2 diabetes.
    Khunti K; Cos X; Rutten G
    Prim Care Diabetes; 2014 Jul; 8(2):119-25. PubMed ID: 24207030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.